528 related articles for article (PubMed ID: 23183941)
21. Coenzyme Q10 reverses mitochondrial dysfunction in atorvastatin-treated mice and increases exercise endurance.
Muraki A; Miyashita K; Mitsuishi M; Tamaki M; Tanaka K; Itoh H
J Appl Physiol (1985); 2012 Aug; 113(3):479-86. PubMed ID: 22653988
[TBL] [Abstract][Full Text] [Related]
22. The effect of moderate-dose versus double-dose statins on patients with acute coronary syndrome in China: Results of the CHILLAS trial.
Zhao SP; Yu BL; Peng DQ; Huo Y
Atherosclerosis; 2014 Apr; 233(2):707-712. PubMed ID: 24603217
[TBL] [Abstract][Full Text] [Related]
23. Summaries for patients. Muscle abnormalities in four patients taking statins to treat unfavorable cholesterol levels.
Ann Intern Med; 2002 Oct; 137(7):I45. PubMed ID: 12353973
[No Abstract] [Full Text] [Related]
24. Failure to recapture cardioprotection with high-dose atorvastatin in coronary artery bypass surgery: a randomised controlled trial.
Ludman AJ; Hausenloy DJ; Babu G; Hasleton J; Venugopal V; Boston-Griffiths E; Yap J; Lawrence D; Hayward M; Kolvekar S; Bognolo G; Rees P; Yellon DM
Basic Res Cardiol; 2011 Nov; 106(6):1387-95. PubMed ID: 21833652
[TBL] [Abstract][Full Text] [Related]
25. Preoperative atorvastatin treatment in CABG patients rapidly improves vein graft redox state by inhibition of Rac1 and NADPH-oxidase activity.
Antoniades C; Bakogiannis C; Tousoulis D; Reilly S; Zhang MH; Paschalis A; Antonopoulos AS; Demosthenous M; Miliou A; Psarros C; Marinou K; Sfyras N; Economopoulos G; Casadei B; Channon KM; Stefanadis C
Circulation; 2010 Sep; 122(11 Suppl):S66-73. PubMed ID: 20837928
[TBL] [Abstract][Full Text] [Related]
26. Safety and efficacy of atorvastatin in heart transplant recipients.
Patel DN; Pagani FD; Koelling TM; Dyke DB; Baliga RR; Cody RJ; Lake KD; Aaronson KD
J Heart Lung Transplant; 2002 Feb; 21(2):204-10. PubMed ID: 11834348
[TBL] [Abstract][Full Text] [Related]
27. High-dose atorvastatin reduces periodontal inflammation: a novel pleiotropic effect of statins.
Subramanian S; Emami H; Vucic E; Singh P; Vijayakumar J; Fifer KM; Alon A; Shankar SS; Farkouh M; Rudd JHF; Fayad ZA; Van Dyke TE; Tawakol A
J Am Coll Cardiol; 2013 Dec; 62(25):2382-2391. PubMed ID: 24070911
[TBL] [Abstract][Full Text] [Related]
28. Safety of high-dose atorvastatin therapy.
Waters DD
Am J Cardiol; 2005 Sep; 96(5A):69F-75F. PubMed ID: 16126026
[TBL] [Abstract][Full Text] [Related]
29. A placebo-controlled trial examining atorvastatin in dyslipidemic patients undergoing CAPD.
Harris KP; Wheeler DC; Chong CC;
Kidney Int; 2002 Apr; 61(4):1469-74. PubMed ID: 11918754
[TBL] [Abstract][Full Text] [Related]
30. [Myopathy due to statins, a dose-dependent effect, and of what kind?].
León Vázquez F; Llanes De Torres R; Morón Merchante I
Aten Primaria; 2002; 30(3):188. PubMed ID: 12139858
[No Abstract] [Full Text] [Related]
31. Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial.
Nissen SE; Tuzcu EM; Schoenhagen P; Brown BG; Ganz P; Vogel RA; Crowe T; Howard G; Cooper CJ; Brodie B; Grines CL; DeMaria AN;
JAMA; 2004 Mar; 291(9):1071-80. PubMed ID: 14996776
[TBL] [Abstract][Full Text] [Related]
32. [Acute cholestatic hepatitis after atorvastatin reintroduction].
de Castro ML; Hermo JA; Baz A; de Luaces C; Pérez R; Clofent J
Gastroenterol Hepatol; 2006 Jan; 29(1):21-4. PubMed ID: 16393626
[TBL] [Abstract][Full Text] [Related]
33. Atorvastatin: a safety and tolerability profile.
Arca M
Drugs; 2007; 67 Suppl 1():63-9. PubMed ID: 17910522
[TBL] [Abstract][Full Text] [Related]
34. Statins do not significantly affect muscle sympathetic nerve activity in humans with nonischemic heart failure: a double-blind placebo-controlled trial.
Horwich TB; Middlekauff HR; Maclellan WR; Fonarow GC
J Card Fail; 2011 Nov; 17(11):879-86. PubMed ID: 22041323
[TBL] [Abstract][Full Text] [Related]
35. Efficacy and tolerability of atorvastatin/fenofibrate fixed-dose combination tablet compared with atorvastatin and fenofibrate monotherapies in patients with dyslipidemia: a 12-week, multicenter, double-blind, randomized, parallel-group study.
Davidson MH; Rooney MW; Drucker J; Eugene Griffin H; Oosman S; Beckert M;
Clin Ther; 2009 Dec; 31(12):2824-38. PubMed ID: 20110022
[TBL] [Abstract][Full Text] [Related]
36. Changes in muscle strength in individuals with statin-induced myopathy: A summary of 3 investigations.
Panza GA; Taylor BA; Dada MR; Thompson PD
J Clin Lipidol; 2015; 9(3):351-6. PubMed ID: 26073393
[TBL] [Abstract][Full Text] [Related]
37. Problems in dealing with very rare adverse effects of new anticancer drugs: the example of trabectedin.
Grosso F; D'Incalci M
Tumori; 2011; 97(2):256. PubMed ID: 21617728
[No Abstract] [Full Text] [Related]
38. No effect of combined coenzyme Q10 and selenium supplementation on atorvastatin-induced myopathy.
Bogsrud MP; Langslet G; Ose L; Arnesen KE; Sm Stuen MC; Malt UF; Woldseth B; Retterstøl K
Scand Cardiovasc J; 2013 Apr; 47(2):80-7. PubMed ID: 23301875
[TBL] [Abstract][Full Text] [Related]
39. Lack of evidence of a clopidogrel-statin interaction in the CHARISMA trial.
Saw J; Brennan DM; Steinhubl SR; Bhatt DL; Mak KH; Fox K; Topol EJ;
J Am Coll Cardiol; 2007 Jul; 50(4):291-5. PubMed ID: 17659194
[TBL] [Abstract][Full Text] [Related]
40. Efficacy of alternate-day dosing versus daily dosing of atorvastatin.
Jafari M; Ebrahimi R; Ahmadi-Kashani M; Balian H; Bashir M
J Cardiovasc Pharmacol Ther; 2003 Jun; 8(2):123-6. PubMed ID: 12808485
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
